Tybost FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved September 24, 2014)
Brand name: Tybost
Generic name: cobicistat
Dosage form: Tablets
Company: Gilead Sciences, Inc.
Treatment for: HIV Infection
Tybost (cobicistat) is a potent inhibitor of cytochrome P450 3A (CYP3A) which acts as a pharmacoenhancing or "boosting" agent for antiviral drugs used in the treatment of HIV infection.
Development timeline for Tybost
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.